Getting the right insights for evidence generation requires fit-for-purpose real world data. This is made harder when you factor in the difficulty of finding data for rare and neurodegenerative diseases.
CENTOGENE will be at ISPOR US, eager to discuss how we can support you with real-world data in the form of our vast, unique Biodatabank, encompassing >800,000 patients (70% of non-European descent), and diagnostics capability for >2,500 rare diseases & >70 M rare disease variants. And we support you with insights via our in-house multiomic, medical and bioinformatics expertise. Join Mario D’Alessandro, Daniel Kimball and Eric Mertz at Booth 206 to find out more!
